19 related articles for article (PubMed ID: 6547993)
1. Autoradiography of
Valuskova P; Farar V; Forczek S; Krizova I; Myslivecek J
Front Pharmacol; 2018; 9():124. PubMed ID: 29515448
[TBL] [Abstract][Full Text] [Related]
2. Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.
Carmine AA; Brogden RN
Drugs; 1985 Aug; 30(2):85-126. PubMed ID: 3928324
[TBL] [Abstract][Full Text] [Related]
3. Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine.
Giachetti A; Giraldo E; Ladinsky H; Montagna E
Br J Pharmacol; 1986 Sep; 89(1):83-90. PubMed ID: 2432979
[TBL] [Abstract][Full Text] [Related]
4. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
5. [3H]Pirenzepine identifies putative M1 muscarinic receptors in human stellate ganglia.
Watson M; Roeske WR; Johnson PC; Yamamura HI
Brain Res; 1984 Jan; 290(1):179-82. PubMed ID: 6546354
[TBL] [Abstract][Full Text] [Related]
6. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
7. [3H]Pirenzepine and [3H]quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization.
Luthin GR; Wolfe BB
Mol Pharmacol; 1984 Sep; 26(2):164-9. PubMed ID: 6548291
[TBL] [Abstract][Full Text] [Related]
8. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
9. Light microscopic autoradiographic localization of [3H]pirenzepine and [3H](-)quinuclidinyl benzilate binding in human stellate ganglia.
Yamamura HI; Watson M; Wamsley JK; Johnson PC; Roeske WR
Life Sci; 1984 Aug; 35(7):753-7. PubMed ID: 6547993
[TBL] [Abstract][Full Text] [Related]
10. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
Nilvebrant L
Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
